Reaction Biology Wins $1.2M SBIR Grant for Screening Platform

The company will use the SBIR funding from the National Cancer Institute to expand its HotSpot drug discovery screening services.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.